CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 15 enrolled
Drug / intervention
Platelet rich fibrin matrixbiological
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00874094
NCT00874094Phase 2Completed
CompareCT.gov

Pilot Evaluation of Platelet Rich Fibrin Matrix (PRFM) for the Correction of Nasolabial Folds

The New York Eye & Ear Infirmary·interventional·Posted Apr 2, 2009·Updated Jul 12, 2013

In Brief

A Phase 2 clinical trial evaluating Platelet rich fibrin matrix for Nasolabial Folds. Completed, enrolled 15 participants across 1 site.

Detailed Summary

Platelets are a component of blood, which contain factors which can enhance wound healing. This study proposes to evaluate the clinical response of laugh lines treated with a concentrated preparation of the subject's own platelets injected into or under the skin by taking serial photographs of the subject's face over a 12 week period. Also, the same preparation will be injected into or under the skin of the arm near the elbows, and serial biopsies will be taken over a 12 week period.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsNasolabial Folds
CountriesUnited States
Collaborators--

Timeline

Phase 2CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedApr 2, 2009
Enrollment StartApr 1, 2008
Primary CompletionJun 1, 2009
Study CompletionJul 1, 2009
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 17.3 years ago

Interventions

Platelet rich fibrin matrixbiological

0-2 cc of autologous platelet rich fibrin matrix injected intra and subdermally to effect nasolabial fold.